ID
37643
Descripción
Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer
Palabras clave
Versiones (1)
- 13/8/19 13/8/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
13 de agosto de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612
Adverse Events
- StudyEvent: ODM
Descripción
Adverse Event
Alias
- UMLS CUI-1
- C0877248
Descripción
Adverse event
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0877248
Descripción
Adverse Event Grade Code
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2985911
Descripción
Adverse Event Start Date Time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C2826806
Descripción
Adverse Event End Date Time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C2826793
Descripción
Adverse Event Outcome
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1705586
Descripción
Adverse Event Ongoing; Adverse Event, Periodic
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826663
- UMLS CUI [2,1]
- C0877248
- UMLS CUI [2,2]
- C0332182
Descripción
Adverse event, Symptom intensity
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0518690
Descripción
Adverse Event Action Taken with Study Treatment
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826626
Descripción
Adverse event, Relationships, Experimental drug
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0304229
Descripción
Adverse event, Therapeutic procedure
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
Descripción
Adverse event, Withdraw
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C2349954
Descripción
Adverse event, Investigator Signature
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C2346576
Descripción
Adverse event, Investigator Signature, Date in time
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C2346576
- UMLS CUI [1,3]
- C0011008
Similar models
Adverse Events
- StudyEvent: ODM
C0877248 (UMLS CUI [2,1])
C0332182 (UMLS CUI [2,2])
C0518690 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,2])
C2346576 (UMLS CUI [1,2])
C2346576 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])